Product Information
PAROXETINE HCL 30 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0940 per EA under NDC 62135054390. Its NADAC has been published 154 times since Sep 13, 2023.
FDA first approved this application on Nov 2, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Chartwell RX LLCNDC
62135054390
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211248FDA Approved
11/2/2021
TE Code
AB
On Market Since
11/2/2021
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 30 MG TABLET has been published 154 times since Sep 13, 2023, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0940 per EA |
|---|---|
| All-time high | $0.1154 (Jan 10, 2024) |
| All-time low | $0.0735 (Nov 20, 2024) |
| 52-week high | $0.1039 |
| 52-week low | $0.0940 |
| Median price | $0.0966 |
| Average price | $0.0976 |
| Largest weekly change | +27.2% (Nov 22, 2023) |
| Weeks tracked | 154 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PAROXETINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 30 MG TABLET, manufactured by Chartwell RX LLC, is $0.0940 per EA (NDC 62135054390), effective Aug 19, 2026.
How has the price of PAROXETINE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 30 MG TABLET has declined 5.1%. It has been tracked across 154 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 30 MG TABLET?
Since Sep 13, 2023, the NADAC for PAROXETINE HCL 30 MG TABLET has ranged from a low of $0.0735 (Nov 20, 2024) to a high of $0.1154 (Jan 10, 2024), with a median of $0.0966 per EA.
Are there cheaper alternatives to PAROXETINE HCL 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PAROXETINE HCL 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE HCL 30 MG TABLET?
PAROXETINE HCL 30 MG TABLET (NDC 62135054390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.